Evidence map›Paper›PMID 21362439›Full record

ArticleToxicology and applied pharmacology2011

Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels.

Menghang Xia, Sampada A Shahane, Ruili Huang, Steven A Titus, Enoch Shum, Yong Zhao, Noel Southall, Wei Zheng, Kristine L Witt, Raymond R Tice and 1 more

Abstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Cell-Based hERG Channel Inhibition Assay in High-Throughput Format.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. The Essential Medicinal Chemistry of Curcumin.Journal of medicinal chemistry · 2017
    Review
  11. Article
  12. Article
  13. Article
  14. Are hERG channel blockers also phospholipidosis inducers?Bioorganic & medicinal chemistry letters · 2013
    Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Menghang XiaNIH Chemical Genomics Center, National Institutes of Health, Bethesda, MD 20892-3370, USA. mxia@mail.nih.gov
Sampada A Shahane
Ruili Huang
Steven A Titus
Enoch Shum
Yong Zhao
Noel Southall
Wei Zheng
Kristine L Witt
Raymond R Tice
Christopher P Austin
National Institutes of Health · USCenter for Effective Philanthropy · USNational Institute of Environmental Health Sciences · US

Funding

NIH Chemical Genomics CenterZIBHG200319 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI AUSTIN, CHRISTOPHER P · 2010 to 2011
$55.9M
TRAINING GRANTS IN ENVIROMENTAL TOXICOLOGYT32ES007020 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ESSIGMANN, JOHN M · 1985 to 2024
$13.1M
Intramural NIH HHS Z99 HG999999NIEHS NIH HHS Y02 ES007020
6 · The paper itself

Abstract

The human ether-a-go-go-related gene (hERG) channel, a member of a family of voltage-gated potassium (K(+)) channels, plays a critical role in the repolarization of the cardiac action potential. The reduction of hERG channel activity as a result of adverse drug effects or genetic mutations may cause QT interval prolongation and potentially leads to acquired long QT syndrome. Thus, screening for hERG channel activity is important in drug development. Cardiotoxicity associated with the inhibition of hERG channels by environmental chemicals is also a public health concern. To assess the inhibitory effects of environmental chemicals on hERG channel function, we screened the National Toxicology Program (NTP) collection of 1408 compounds by measuring thallium influx into cells through hERG channels. Seventeen compounds with hERG channel inhibition were identified with IC(50) potencies ranging from 0.26 to 22μM. Twelve of these compounds were confirmed as hERG channel blockers in an automated whole cell patch clamp experiment. In addition, we investigated the structure-activity relationship of seven compounds belonging to the quaternary ammonium compound (QAC) series on hERG channel inhibition. Among four active QAC compounds, tetra-n-octylammonium bromide was the most potent with an IC(50) value of 260nM in the thallium influx assay and 80nM in the patch clamp assay. The potency of this class of hERG channel inhibitors appears to depend on the number and length of their aliphatic side-chains surrounding the charged nitrogen. Profiling environmental compound libraries for hERG channel inhibition provides information useful in prioritizing these compounds for cardiotoxicity assessment in vivo.

Indexed as

Arrhythmias, CardiacCell Line, TumorCell SurvivalDrug Evaluation, PreclinicalEther-A-Go-Go Potassium ChannelsHumansInhibitory Concentration 50Patch-Clamp TechniquesQuaternary Ammonium CompoundsStructure-Activity RelationshipEther-A-Go-Go Potassium ChannelsQuaternary Ammonium Compounds

Identifiers

PMID21362439
PMCPMC3079779
OpenAlexW2110575201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.